FeaturedNeurologyNeuroscience·October 6, 2024·5 min readStudy Finds Wegovy Reduces COVID-19 Death Risk by One-ThirdA new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%. The study followed more than 17,000 participants with heart disease and obesity, showing that Wegovy decreased the likelihood of death from cardiovascular disease by 15% and other causes by 23%.Read More
FeaturedNeurologyNeuroscience·October 6, 2024·6 min readMicroplastics Found in Human Brains, Raising Health ConcernsA new study has found microplastics in human brains for the first time, raising concerns about the potential health impact. Researchers analyzed samples from autopsies and discovered an accumulation of plastic particles in brain tissue, likely due to exposure through food, water, and air.Read More
FeaturedNeurologyNeuroscience·October 5, 2024·5 min readNew Molecule Offers Hope for Parkinson’s by Outperforming L-DopaA new study has discovered that ophthalmic acid, a molecule in the brain, acts like a neurotransmitter to regulate motor function, similar to dopamine. In Parkinson’s mouse models, this molecule improved movement for over 20 hours—far longer than the effects of the current treatment, L-dopa.Read More
FeaturedNeurologyNeuroscience·October 4, 2024·6 min readCOVID-19 Affects Memory and Cognition for Up to a YearHealthy adults who contracted COVID-19 had subtle but measurable declines in memory and cognitive performance lasting up to a year. These differences were found through sensitive testing under controlled conditions, though all scores remained within normal ranges, and none of the participants reported lasting cognitive symptoms.Read More
FeaturedNeurologyNeuroscience·October 4, 2024·6 min readAlzheimer’s Brain Shrinkage Follows No Single PatternA new study finds that brain shrinkage in Alzheimer's patients does not follow a uniform pattern. Researchers examined thousands of brain scans and found that individuals showed varied shrinkage patterns over time. Those with faster shrinkage in specific brain regions were more likely to develop Alzheimer’s. This personalized approach to brain mapping may lead to tailored treatments based on individual brain changes.Read More
FeaturedNeurologyNeuroscience·October 3, 2024·6 min readDual-Targeting Drug Halts Tau Accumulation in Alzheimer’sScientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in Alzheimer's disease. This peptide inhibitor, RI-AG03, effectively prevents Tau buildup in lab studies and fruit flies, offering hope for new Alzheimer's treatments.Read More
FeaturedNeurologyNeurosciencePain·October 3, 2024·4 min readChronic Pain Patients Favor Cannabis LegalizationA study found that 71% of adults with chronic pain support federal legalization of medical cannabis, compared to 59% of physicians. The research highlights a gap in attitudes toward cannabis policies between patients and doctors, especially regarding insurance coverage for cannabis treatments.Read More
FeaturedNeurologyNeurosciencePsychology·October 2, 2024·4 min readCannabis Pill Reduces Agitation in Alzheimer’s Patients by 30%A new study reveals that dronabinol, a synthetic form of THC, can reduce agitation in Alzheimer’s patients by 30%. Unlike current medications, dronabinol showed fewer side effects, such as delirium or seizures, making it a safer alternative.Read More
FeaturedNeurologyNeuroscience·October 2, 2024·4 min readPersonalized Immune Therapy Offers Hope for MS PatientsA new study explores the use of tolerogenic dendritic cells (tolDCs) to restore immune balance in multiple sclerosis (MS) patients without compromising their immune system. The research reveals that MS patients’ immune cells have a pro-inflammatory signature, even after being modified for therapy.Read More
FeaturedNeurologyNeuroscience·October 2, 2024·4 min readTime of Day Affects Key Biomarkers for Alzheimer’s DiagnosisNew research shows that the time of day when blood samples are taken significantly impacts the levels of Alzheimer's biomarkers, including p-tau217, which is crucial for early diagnosis. Biomarker levels were found to be lowest in the morning and highest in the evening, indicating that timing could affect dementia diagnosis and monitoring.Read More
FeaturedNeuroscience·October 2, 2024·6 min readFirst Full Brain Map of Adult Fruit Fly CreatedResearchers have created the first neuron-by-neuron map of an adult fruit fly brain, marking a major achievement in brain mapping. The map, built using 21 million images, connects nearly 140,000 neurons and 50 million synapses, making it the most complex brain map of any adult animal to date.Read More
Brain CancerFeaturedNeurologyNeuroscience·October 2, 2024·4 min readMRI-Guided Radiation Shows Promise for GlioblastomaMRI-guided radiation, or MRI-linac, can monitor glioblastoma tumor changes in real-time during radiation therapy. Researchers found that daily MRI scans accurately matched tumor changes detected by standard imaging 74% of the time and predicted growth earlier in 26% of cases.Read More
